Skip to content
★ Sign in to follow
GH
Total declarations
10
Company
1
▲ Purchases (1 ops.)
€40k
▼ Sales (2 ops.)
€113k

Latest filing published 11 Mar 2021 for Neuronetics, Inc., €68k.

Filing timeline

BuySale
Gregory Harper

Insider track record

Disclosed buys
1
Disclosed sells
2
Signal history

Closed purchases

Market purchases
1

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Since each purchase

  • Filed 18 Dec 2019 · 2518 days ago · €40k
    +96.4%
    Entry US$4.50 · Close at T+365 US$8.84

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Gregory Harper: trading record in brief

Gregory Harper appears in our data through filings on Neuronetics, Inc. shares, published by SEC (Form 4). Between 8 March 2019 and 9 March 2021, the trades on record add up to 10 filings.

Both buying and selling appear: 1 purchase worth €40k, against 2 sales worth €113k. Netting one side against the other leaves €73k of net selling. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 5 share grants and 2 option exercises. So far in 2021, the count stands at no purchases and 2 sales.

The newest entry dates from 11 March 2021: an open-market sale of €68k, in Neuronetics, Inc. The last insider purchase was made public on 18 December 2019, 2,518 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Gregory Harper

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations10 total
  • ▼
    VP of Prod. Dev. & OperationsExecutivesNeuronetics, Inc.
    80,927 USD28SEC
    5,524 shares@ US$14.6522.1% of flowCommon StockSEC:0000925421-21-000109:0
  • ◆
    VP of Prod. Dev. & OperationsExecutivesNeuronetics, Inc.
    0SEC
    17,085 shares0Common StockSEC:0000925421-21-000075:0
  • ▼
    VP of Prod. Dev. & OperationsExecutivesNeuronetics, Inc.
    54,065 USD27SEC
    2,969 shares@ US$18.2114.5% of flowCommon StockSEC:0000925421-21-000053:0
  • ◆
    VP of R&D, Ops. and Prod. Dev.ExecutivesNeuronetics, Inc.
    2,036 USD13SEC
    1,018 shares@ US$2.001.9% of flowCommon StockSEC:0001192482-20-000220:0
  • ◆
    VP of R&D, Ops. and Prod. Dev.ExecutivesNeuronetics, Inc.
    0SEC
    44,500 sharesCommon StockSEC:0001192482-20-000204:0
  • ◆
    VP of R&D, Ops. and Prod. Dev.ExecutivesNeuronetics, Inc.
    0SEC
    35,000 sharesCommon StockSEC:0001209191-20-004001:0
  • ▲
    VP of R&D, Ops. and Prod. Dev.ExecutivesNeuronetics, Inc.
    44,000 USD31SEC
    10,000 shares@ US$4.4020.2% of flowCommon StockSEC:0001209191-19-061145:0
    Canonical exit: 15 Mar 2020 (T+90)
  • ◇
    VP of R&D, Ops. and Prod. Dev.ExecutivesNeuronetics, Inc.
    61,289 USD14SEC
    19,213 shares@ US$3.1928.1% of flowCommon StockSEC:0001209191-19-043415:0
  • ◇
    VP of R&D, Ops. and Prod. Dev.ExecutivesNeuronetics, Inc.
    111,650 USD16SEC
    35,000 shares@ US$3.1950.7% of flowCommon StockSEC:0001209191-19-025592:0
  • ◆
    VP of R&D, Ops. and Prod. Dev.ExecutivesNeuronetics, Inc.
    0SEC
    11,267 sharesCommon StockSEC:0001209191-19-018612:0

10 of 10 declarations